跳至主要内容
临床试验/NCT05126225
NCT05126225已完成不适用

Buddhist Understanding and Reduction of Myanmar Experiences of HIV Stigma and Exclusion

University of California, Los Angeles4 个研究点 分布在 2 个国家目标入组 19 人开始时间: 2020年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
19
试验地点
4
主要终点
Change in Stigma Score From Baseline to End of Intervention in Protocol Group

研究概览

简要总结

This project aims to explore a multi-leveled conceptualization of the effects of HIV stigma on HIV care engagement in Myanmar by conducting a mixed-method study.

详细描述

This project is to explore how Myanmar People Living With HIV (PLWH) experience and manage HIV stigma as inspired by Buddhist teaching, and to adapt an evidence-based stigma-reduction intervention to tailor treatment for the unique needs of Myanmar People Living With HIV.

A stigma-reduction intervention will be adopted to the needs of Myanmar People Living With HIV with six focus groups.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • HIV-Positive
  • Care by Myanmar Positive Group/CMRU
  • Living in Myanmar/Thailand
  • can stay in the period of intervention

排除标准

  • Living outside of Myanmar/Thailand
  • Not care by MPG/CMRU
  • Cannot stay for the study period

结局指标

主要结局

Change in Stigma Score From Baseline to End of Intervention in Protocol Group

时间窗: Baseline and 8 weeks

Perceived Stigma Scale (PSS). Each item is measured using a 4-point Likert scale and the scale contains four factors: personalized stigma (18 items, subscore total 18-72), disclosure concerns (12 items, subscore total 12-48), negative self-image (9 items, subscore total 9-36), and concern with public attitudes about people with HIV (12 items, subscore total 12-48). Each factor is scored separately, with total score is computed by summing all 40 items, with a minimum total PSS score of 40 and a maximum possible score of 160. Raw PSS scores were transformed into Stigma scores 1-4. Higher scores reflect higher levels of perceived stigma.

次要结局

  • Change in QOL Score From Baseline to End of Intervention in the Protocol Group(Baseline and 8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Weiti Chen, RN, CNM, PhD, FAAN

Principal Investigator

University of California, Los Angeles

研究点 (4)

Loading locations...

相似试验